It benefits digestive health and enhances natural GLP-1 release
The point isn't that any of these ingredients are dangerous in normal amounts
In particular, microdosingusing smaller-than-standard doseshas emerged as an approach for individuals who seek these broader advantages while minimizing potential side effects
These next-generation agents engage not only GLP-1 receptors but also those for other gastro-entero-pancreatic hormones such as glucose-dependent insulinotropic polypeptide (GIP), glucagon, amylin, and peptide YY to enhance energy uptake, storage, and expenditure through synergistic mechanisms
Without a provider review, these contraindications may not be identified before treatment begins
[1] These incretin-based therapies have gained significant attention due to their effectiveness in lowering blood glucose levels and promoting weight loss